IMIDomics
PrivateLast Round
Strategic
Mar 4, 2024
Total Funding Raised
$16.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
IMIDomics is a biotechnology company that develops first-in-class medicines and diagnostic markers for immune-mediated inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IMIDomics Comparables
Compare IMIDomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mirador Therapeutics | 81% | |
| Scipher Medicine | 78% | |
| Immunai | 78% | |
IMIDomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 4, 2024 | ||||
| Series A | Jul 27, 2021 |
Key People
Founding team and executive leadership
IMIDomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Pritzker Organization | Series A |
| DNS Capital | Series A |
| Tao Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 298% MoM.
- Dec 7, 2025
Monthly visitors increased 503% MoM.
IMIDomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IMIDomics's valuation, stock price, and market status.